Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

62.35
+0.26500.43%
Volume:3.17M
Turnover:198.72M
Market Cap:276.75B
PE:19.85
High:63.25
Open:62.19
Low:62.18
Close:62.08
Loading ...

Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
27 Feb

Novo Resources Advances Exploration Amid Challenges

TIPRANKS
·
27 Feb

Eli Lilly to build 4 more manufacturing sites in US

Yahoo Finance
·
26 Feb

Top Stock Reports for Charles Schwab, Gilead Sciences & Medtronic

Zacks
·
26 Feb

Novo Nordisk A/S (NVO): Among the Stocks That Will Go to The Moon According to Analysts

Insider Monkey
·
26 Feb

Hims & Hers tumbles 27% as investors fear uncertainty without compounded weight-loss drugs

Yahoo Finance
·
26 Feb

Novo Nordisk A/S (NVO): Jim Cramer’s Take on Weight Loss Drug Giant’s Future

Insider Monkey
·
25 Feb

Novo Nordisk Shares Rise as Hims & Hers to Stop Mimicking Weight-Loss Drugs

Dow Jones
·
25 Feb

Novo Nordisk (0QIU) Gets a Hold from Bernstein

TIPRANKS
·
25 Feb

Novo Nordisk A/S (NVO): A High Growth Mega Cap Stock You Can Buy and Hold for the Next 5 Years

Insider Monkey
·
25 Feb

Eli Lilly Cuts Price Of Weight-Loss Drug Zepbound For Self-Paying Patients

Dow Jones
·
25 Feb

Novo shares rise as HIMS halt sales of some obesity drugs

Investing.com
·
25 Feb

Novo Nordisk's stock is rallying as Hims & Hers' stock falters. An Ozempic alternative won't be available for long.

Dow Jones
·
25 Feb

Analysts Conflicted on These Healthcare Names: Hims & Hers Health (HIMS) and Novo Nordisk (NVO)

TIPRANKS
·
25 Feb

Novo Nordisk Shares Jumped 3.7% On HIMS To Stop Selling Weight-Loss Drugs

Tiger Newspress
·
25 Feb

In China you can get Ozempic and Wegovy within the hour for just $100 a month

Dow Jones
·
25 Feb

Novo Nordisk A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
25 Feb

Here is Why Novo Nordisk A/S (NVO) is Among the Most Oversold Pharma Stocks to Buy According to Analysts

Insider Monkey
·
25 Feb

Novo Nordisk A/S (NVO): Among Renaissance Technologies Portfolio’s Top Stock Picks

Insider Monkey
·
24 Feb

UBS Reaffirms Their Buy Rating on Novo Nordisk (0QIU)

TIPRANKS
·
24 Feb